New hope for advanced breast cancer: drug combo trial launches
Disease control
Recruiting now
This study tests a combination of two drugs, ribociclib and anastrozole, in people with a common type of advanced breast cancer (hormone receptor-positive, HER2-negative) that has spread or come back. The goal is to see if the combination works better and is safe. About 86 adults…
Phase: PHASE1, PHASE2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated May 11, 2026 20:49 UTC